только у нас скачать шаблон dle скачивать рекомендуем

Фото видео монтаж » Видео уроки » Vaccine Pharmacovigilance [Vaccinovigilance]

Vaccine Pharmacovigilance [Vaccinovigilance]

Vaccine Pharmacovigilance [Vaccinovigilance]

Vaccine Pharmacovigilance [Vaccinovigilance]
Published 3/2024
MP4 | Video: h264, 1920x1080 | Audio: AAC, 44.1 KHz
Language: English

| Size: 808.32 MB[/center]
| Duration: 1h 42m
Vaccine PV, Pharmacovigilance, Vaccine Safety, Adverse Events Following Immunization, AEFI

What you'll learn

Basics of Vaccines and Vaccine Pharmacovigilance

Brighton Collaboration criteria

Why PV of Vaccines is different from other drugs

Why Vaccine Safety Monitoring

Elements to consider in Vaccine PV

Adverse events following immunization [AEFI]

Collection, Analysis and Presentation of Vaccine safety data

Differences between Vaccines and Drugs in signal detection

Requirements

Laptop / PC/ Cellphone

Good Internet connection

Basic English

Description

Title: Vaccine Pharmacovigilance [Vaccinovigilance]Ensuring Vaccine Safety for Public Health.Are you interested in playing a crucial role in safeguarding public health through vaccine safety? Enroll in our specialized course, "Vaccine Pharmacovigilance [Vaccinovigilance]" to gain the knowledge and skills needed to monitor and assess the safety of vaccines.Key Highlights:Basics of Vaccines and Vaccine PharmacovigilanceBrighton Collaboration criteriaAdverse events following immunization [AEFI]How PV of Vaccines is different from other drugsWhy Vaccine Safety Monitoring is requiredElements to consider in Vaccine PVCollection, Analysis and Presentation of Vaccine safety dataDifferences between Vaccines and Drugs in signal detectionWhy Choose This Course?Specialized Knowledge: Vaccine pharmacovigilance is a specialized field with growing importance. Equip yourself with the knowledge and skills needed to excel in this critical area of public health.Career Advancement: Enhance your career prospects in public health, pharmacovigilance, or regulatory affairs. Gain a competitive edge with expertise in vaccine safety.Impactful Contribution: Make a meaningful contribution to public health by ensuring the safety and efficacy of vaccines. Your work in vaccine pharmacovigilance can help save lives and prevent diseases.Who Should Enroll:Pharmacovigilance ProfessionalsPublic Health ProfessionalsPharmacistsHealthcare WorkersRegulatory Affairs ProfessionalsAnyone interested in vaccine safety and public healthDon't miss this opportunity to become a key player in vaccine safety. Enroll now and embark on a rewarding journey to protect public health through vaccine pharmacovigilance [Vaccinovigilance]!Note: Basic knowledge of pharmacovigilance and vaccines is recommended but not required.

Overview

Section 1: Module 1 - Fundamentals of Vaccine Pharmacovigilance

Lecture 1 About the course

Lecture 2 Introduction, Vaccines and types, Brighton collaboration

Lecture 3 Why PV of Vaccines is different from other drugs

Lecture 4 Why Vaccine safety monitoring

Section 2: Module 2 - Elements to consider in Vaccine PV, AEFI, and Vaccination failure

Lecture 5 Elements to consider in Vaccine PV

Lecture 6 Adverse events following immunization [AEFI]

Lecture 7 Vaccination failure Algorithm

Lecture 8 Data collection checklist for suspected vaccination failure

Section 3: Module 3 - Collection, Analysis and Presentation of Vaccine safety data

Lecture 9 Data collection

Lecture 10 Data analysis

Lecture 11 Data presentation

Lecture 12 Sample report form for AEFI

Section 4: Module 4 - Safety Surveillance

Lecture 13 Differences between Vaccines and Drugs in Signal detection

Section 5: Congratulations

Lecture 14 What to do after this training

Pharmacovigilance professionals,Pharmacy, Medical and Life science students,Public Health Professionals,Pharmacists,Healthcare Workers,Anyone interested in vaccine safety and public health









Free search engine download: Vaccine Pharmacovigilance Vaccinovigilance
Poproshajka




Информация
Посетители, находящиеся в группе Гости, не могут оставлять комментарии к данной публикации.